Sensus Healthcare, Inc.
$4.06
▼
-2.14%
2026-04-21 09:36:00
sensushealthcare.com
NCM: SRTS
Explore Sensus Healthcare, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$66.84 M
Current Price
$4.06
52W High / Low
$5.92 / $3.03
Stock P/E
—
Book Value
$1.57
Dividend Yield
—
ROCE
-21.33%
ROE
-14.85%
Face Value
—
EPS
$-0.47
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
60
Beta
1.28
Debt / Equity
0.98
Current Ratio
9.72
Quick Ratio
6.63
Forward P/E
70.9
Price / Sales
2.69
Enterprise Value
$52.3 M
EV / EBITDA
-5.27
EV / Revenue
1.9
Rating
None
Target Price
$6.88
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Pacific Biosciences of California, Inc. | $1.74 | — | $510.38 M | — | -78.39% | -2.13% | $2.73 / $0.85 | $0.02 |
| 2. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 3. | Xtant Medical Holdings, Inc. | $0.5 | 15.1 | $75.1 M | — | 11.26% | 10.59% | $0.95 / $0.39 | $0.36 |
| 4. | SS Innovations International, Inc. | $4.85 | — | $971.12 M | — | -17.08% | -46.94% | $22.42 / $3.02 | $0.2 |
| 5. | Axogen, Inc. | $37.23 | — | $2 B | — | -3.96% | -13.49% | $39.99 / $9.22 | $2.73 |
| 6. | ENvue Medical, Inc. | $1.51 | — | $5.59 M | — | -394.93% | -30.51% | $75.48 / $0.99 | $42 |
| 7. | GE HealthCare Technologies Inc. | $71.58 | 15.76 | $32.85 B | 0.19% | 9.93% | 22.38% | $89.77 / $59.95 | $22.77 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 4.94 M | 6.88 M | 7.32 M | 8.34 M | 13.07 M | — |
| Operating Profit | -3.15 M | -2.57 M | -1.94 M | -2.65 M | 1.73 M | — |
| Net Profit | -3.17 M | -0.94 M | -1.04 M | -2.57 M | 1.55 M | — |
| EPS in Rs | -0.19 | -0.06 | -0.06 | -0.16 | 0.09 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 27.48 M | 41.81 M | 24.41 M | 44.53 M |
| Operating Profit | -10.31 M | 8.09 M | -0.38 M | 14.83 M |
| Net Profit | -7.72 M | 6.65 M | 0.48 M | 24.24 M |
| EPS in Rs | -0.47 | 0.4 | 0.03 | 1.47 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 53.04 M | 62.16 M | 53.71 M | 56.73 M |
| Total Liabilities | 4.94 M | 6.34 M | 4.87 M | 8.67 M |
| Equity | 48.1 M | 55.83 M | 48.84 M | 48.07 M |
| Current Assets | 45.89 M | 56.74 M | 49.53 M | 53.24 M |
| Current Liabilities | 4.72 M | 5.88 M | 4.21 M | 7.7 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 0.53 M | -0.83 M | -2.15 M | -1.41 M |
| Investing CF | -0.2 M | -0.28 M | -0.19 M | 14.84 M |
| Financing CF | -0.3 M | 0.01 M | -0.04 M | -2.43 M |
| Free CF | 0.33 M | -1.11 M | -2.37 M | -1.57 M |
| Capex | -0.2 M | -0.28 M | -0.23 M | -0.16 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 71.31% | -45.2% | — | — |
| Earnings Growth % | 1270.52% | -98% | — | — |
| Profit Margin % | 15.9% | 1.99% | 54.44% | — |
| Operating Margin % | 19.35% | -1.57% | 33.3% | — |
| Gross Margin % | 58.44% | 57.61% | 66.53% | — |
| EBITDA Margin % | 20.38% | 0.32% | 34.45% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.